drugset / Trial / NCT01686256

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

NCT01686256 ↗

Phase 1 Completed 12 enrolled Endocyte
NaSingle-groupOpen-labelOther

Summary

A Multi-Center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women with Suspected Ovarian or Endometrial Cancer. Phase I - The proposed indication for FolateScan is disease or pathological assessment of ovarian or endometrial masses.

Timeline

Start
2001-08
Primary completion
2004-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject TECHNETIUM (99MTC) ETARFOLATIDE Diagnostic / imaging agent — —